IMARC Group, a leading market research company, has recently releases report titledHybrid Imaging Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028, The study provides a detailed analysis of the industry, including the globalhybrid imaging marketsize, share, trends, and growth forecast. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
Report Highlights:
How big is the hybrid imaging market?
The global hybrid imaging market size reached US$ 7.9 Billion in2022. Looking forward, IMARC Group expects the market to reach US$ 10.7 Billion by2028, exhibiting a growth rate (CAGR) of 4.9% during2023-2028.
What is Hybrid Imaging?
Hybrid imaging is a medical imaging technique that combines two or more different imaging modalities to provide a comprehensive view of the internal structures and functions of the human body. This approach harnesses the strengths of each modality, such as computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), and single-photon emission computed tomography (SPECT), to offer a more detailed and informative assessment. It aids in early disease detection, precise tumor localization, and the assessment of treatment effectiveness. The benefits of hybrid imaging include improved diagnostic accuracy, reduced radiation exposure, and enhanced patient care through personalized treatment planning.
Request for a sample copy of this report:https://www.imarcgroup.com/hybrid-imaging-market/requestsample
What are the growth prospects and trends in the hybrid imaging industry?
The increasing prevalence of diseases like cancer and cardiovascular disorders necessitates accurate diagnostic tools, boosting the demand for hybrid imaging. In addition to this, ongoing innovations in imaging technologies enhance the capabilities and applicability of hybrid imaging systems thus fostering its market growth. In line with this, the ability of hybrid imaging to detect diseases at an early stage enhances treatment outcomes thereby favoring the market growth. Besides this, tailoring treatments to individual patient profiles is facilitated by the precise data provided by hybrid imaging thus propelling the market growth. Furthermore, hybrid imaging techniques often use lower radiation doses, making them safer for patients thereby proliferating the market growth. Moreover, hybrid imaging plays a vital role in clinical trials and drug development, spurring its use in research settings thus contributing to the market growth. Additionally, a growing elderly population is more prone to age-related diseases, increasing the need for diagnostic tools like hybrid imaging thereby fueling the market growth.
What is included in market segmentation?
The report has segmented the market into the following categories:
Breakup by Type:
- PET/CT Systems
- SPET/CT Systems
- PET/MR Systems
- OCT/Fundus Imaging System
- Others
Breakup by Application:
- Oncology
- Ophthalmology
- Cardiology
- Brain and Neurology
- Others
Breakup by End User:
- Hospitals
- Diagnostic Imaging Centers
- Others
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Who are the key players operating in the industry?
The report covers the major market players including:
- Bruker Corporation
- Canon Medical Systems Corporation
- Cubresa Inc.
- FUJIFILM VisualSonics Inc. (FUJIFILM Sonosite)
- GE HealthCare Technologies Inc. (General Electric Company)
- Koninklijke Philips N.V.
- Mediso Ltd.
- MILabs B.V. (Rigaku Corporation)
- MR Solutions Ltd.
- Siemens Healthineers AG (Siemens AG)
Browse the full report with TOC and list of Figures:https://www.imarcgroup.com/hybrid-imaging-market
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email:sales@imarcgroup.com
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/
